on Relief Therapeutics Holding SA (ETR:RLF)
Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger
Relief Therapeutics Holding SA has announced an extraordinary general meeting (EGM) set for November 14, 2025, in Geneva. The primary agenda is to gain shareholder approval for a business merger with NeuroX Group SA.
Key proposals include a capital increase through issuing 140 million new shares to be exchanged for NeuroX shares, and the election of new board members: Walid Hanna, Olaf Blanke, Michael Stuenkel, and Martin Reiss. Gregory Van Beek will remain on the board to oversee the transition. The proposed merger includes renaming the combined entity to MindMaze Therapeutics Holding SA.
Details about the EGM, including agenda and participation options, will be sent to registered shareholders. Further information is accessible on Relief's website.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Relief Therapeutics Holding SA news